Indian Journal of Geo-Marine Sciences

Open Access Open Access  Restricted Access Subscription Access

The Cytotoxic Activity of Sponges and Tunicates from Turkish Aegean Sea


Affiliations
1 Agri Ibrahim Cecen University, Faculty of Pharmacy, Department of Pharmacognosy, Agri – 04100, Turkey
2 Yıldız Technical University, Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Istanbul – 34220, Turkey
3 Lokman Hekim University, Faculty of Pharmacy, Department of Pharmacognosy, Ankara – 06560, Turkey
 

The enormous bioactive components of different species from marine habitats make them attractive candidates for the discovery of new therapeutic active substances in several diseases such as cancer. Sea sponge and tunicate materials are the ideal sources of new chemotherapeutics for various cancers due to their rich metabolites. The fundamental purpose of the current study is to investigate the cytotoxic activity of methanolic crude extracts of sponges (Agelas oroides and Cladocora caespitosa) and tunicates (Ascidiella aspersa and Styela clava) collected from the Aegean Sea. The cytotoxic activity and the anti-cancer activity of the extracts was carried out by sodium 3´- [1- (diphenyl aminocarbonyl)-3,4-tetrazolium] -bis (4-methoxy 6-nitro) benzene sulfonic acid hydrate (XTT) on gastric adenocarcinoma cell line AGS, prostate cancer cell line PC-3, neuroblastoma cell line SH-SY5Y, and mouse fibroblast cell line L929. The extracts of sponge and tunicate were found to cause different cytotoxic effects on different cancer cells, largely in a concentration-dependent manner. It is found that the extracts exhibited high anti-cancer activities in neuroblastoma and prostate cancer cell lines at concentrations of 3 and 5 mg/ml. No significant cytotoxic activity was found in L929 cells. In addition, the microscopic examination of cells treated with the extracts shows that the extracts cause morphological changes with cellular rounding, which could be associated with apoptosis.

Keywords

Anti-Cancer Activity, Cytotoxic Activity, Marine Natural Products, Sea Sponge, Tunicate.
User
Notifications
Font Size

  • Khalifa S A M, Elias N, Farag M A, Chen L, Saeed A, et al., Marine Natural Products: A Source of Novel Anticancer Drugs, Mar Drugs, 17 (9) (2019) p. 491.

  • Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A, et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68 (6) (2018) 394-424. 10.3322/caac.21492

  • Sung H, Ferlay J, Siegel R L, Laversanne M, Soerjomataram I, et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, 71 (3) (2021) 209-249. 10.3322/caac.21660

  • Menis J & Twelves C, Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer, Breast Cancer (Dove Med Press), 2011 (3) (2011) 101-111. 10.2147/BCTT.S21741

  • Gesto D S, Cerqueira N M F S A, Fernandes P A & Ramos M J, Gemcitabine: A Critical Nucleoside for Cancer Therapy, Curr Med Chem, 19 (7) (2012) 1076-1087. 10.2174/092986712799320682

  • Krauss A C, Gao X, Li L, Manning M L, Patel P, et al., FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia, Clin Cancer Res, 25 (9) (2019) p. 2685. 10.1158/1078-0432.CCR-18-2990

  • Pantazopoulou A, Galmarini C M & Peñalva M A, Molecular basis of resistance to the microtubule-depolymerizing antitumor compound plocabulin, Sci Rep, 8 (1) (2018) p. 8616. 10.1038/s41598-018-26736-3

  • Cheng X, Li J, Tanaka K, Majumder U, Milinichik A Z, et al., MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity, Mol Cancer Ther, 17 (12) (2018) 2665-2675. 10.1158/1535-7163.Mct-17-1215

  • Mehbub M F, Lei J, Franco C & Zhang W, Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives, Mar Drugs, 12 (8) (2014) 4539-4577. 10.3390/md12084539

  • Livett B G, Gayler K R & Khalil Z, Drugs from the Sea: Conopeptides as Potential Therapeutics, Curr Med Chem, 11 (13) (2004) 1715-1723. 10.2174/0929867043364928

  • Essack M, Bajic V B & Archer J A, Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment, Mar Drugs, 9 (9) (2011) 1580-606. 10.3390/md9091580

  • Calcabrini C, Catanzaro E, Bishayee A, Turrini E & Fimognari C, Marine Sponge Natural Products with Anticancer Potential: An Updated Review, Mar Drugs, 15 (10) (2017) p. 310. 10.3390/md15100310

  • Ramesh C, Tulasi B R, Raju M, Thakur N & Dufosse L, Marine Natural Products from Tunicates and Their Associated Microbes, Mar Drugs, 19 (6) (2021) p. 308. 10.3390/md19060308

  • Gordon E M, Sankhala K K, Chawla N & Chawla S P, Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives, Adv Ther, 33 (7) (2016) 1055-1071. 10.1007/s12325-016-0344-3

  • Elez M E, Tabernero J, Geary D, Macarulla T, Kang S P, et al., First-in-human phase I study of Lurbinectedin (PM01183) in patients with advanced solid tumors, Clin Cancer Res, 20 (8) (2014) 2205-2214. 10.1158/1078-0432.Ccr-13-1880

  • Gaillard S, Ghamande S A, Pardo B, Lorusso D, Vergote I, et al., CORAIL trial: Randomized phase III study of lurbinectedin (PM01183) versus pegylated liposomal doxorubicin (PLD) or topotecan (T) in patients with platinum-resistant ovarian cancer, J Clin Oncol, 34 (15) (2016) 5597. 10.1200/JCO.2016.34.15_suppl.TPS5597

  • Mayer A M S (ed), Marine Pharmacology Approved Marine Drugs, World Wide Web electronic publication. https://www.marinepharmacology.org/approved version (31.01.2023)

  • White K M, Rosales R, Yildiz S, Kehrer T, Miorin L, et al., Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A, Science, 371 (6532) (2021) 926-931. 10.1126/science.abf4058

  • Mayer A M S (ed), Marine Pharmacology Clinical Pipeline, World Wide Web electronic publication. https://www. marinepharmacology.org version (31.01.2023)

  • İnan B, Çakır Koç R & Özçimen D, Comparison of the anticancer effect of microalgal oils and microalgal oil-loaded electrosprayed nanoparticles against PC-3, SHSY-5Y and AGS cell lines, Artif Cells Nanomed Biotechnol, 49 (1) (2021) 381-389. 10.1080/21691401.2021.1906263

  • Jumeri & Kim S M, Antioxidant and anticancer activities of enzymatic hydrolysates of solitary tunicate (Styela clava), Food Sci Biotechnol, 20 (4) (2011) p. 1075. 10.1007/s10068-011-0146-y

  • Ferretti C, Marengo B, De Ciucis C, Nitti M, Pronzato M A, et al., Effects of Agelas oroides and Petrosia ficiformis crude extracts on human neuroblastoma cell survival, Int J Oncol, 30 (1) (2007) 161-169. 10.3892/ijo.30.1.161

  • Prado M P, Torres Y R, Berlinck R G S, Desiderá C, Sanchez M A, et al., Effects of marine organisms extracts on microtubule integrity and cell cycle progression in cultured cells, J Exp Mar Biol Ecol, 313 (1) (2004) 125-137. https://doi.org/10.1016/j.jembe.2004.08.008

  • Azevedo L G, Muccillo-Baisch A L, Filgueira D M V B, Boyle R T, Ramos D F, et al., Comparative cytotoxic and anti-tuberculosis activity of Aplysina caissara marine sponge crude extracts, Comp Biochem Physiol C Toxicol Pharmacol, 147 (1) (2008) 36-42. https://doi.org/10.1016/j.cbpc.2007.07.007

  • Aoki S, Wei H, Matsui K, Rachmat R & Kobayashi M, Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis, Bioorg Med Chem, 11 (9) (2003) 1969-1973. 10.1016/s0968-0896(03)00086-5


Abstract Views: 124

PDF Views: 101




  • The Cytotoxic Activity of Sponges and Tunicates from Turkish Aegean Sea

Abstract Views: 124  |  PDF Views: 101

Authors

İ S Uras
Agri Ibrahim Cecen University, Faculty of Pharmacy, Department of Pharmacognosy, Agri – 04100, Turkey
B Mutlu
Yıldız Technical University, Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Istanbul – 34220, Turkey
R Ç Koç
Yıldız Technical University, Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Istanbul – 34220, Turkey
B Konuklugil
Lokman Hekim University, Faculty of Pharmacy, Department of Pharmacognosy, Ankara – 06560, Turkey

Abstract


The enormous bioactive components of different species from marine habitats make them attractive candidates for the discovery of new therapeutic active substances in several diseases such as cancer. Sea sponge and tunicate materials are the ideal sources of new chemotherapeutics for various cancers due to their rich metabolites. The fundamental purpose of the current study is to investigate the cytotoxic activity of methanolic crude extracts of sponges (Agelas oroides and Cladocora caespitosa) and tunicates (Ascidiella aspersa and Styela clava) collected from the Aegean Sea. The cytotoxic activity and the anti-cancer activity of the extracts was carried out by sodium 3´- [1- (diphenyl aminocarbonyl)-3,4-tetrazolium] -bis (4-methoxy 6-nitro) benzene sulfonic acid hydrate (XTT) on gastric adenocarcinoma cell line AGS, prostate cancer cell line PC-3, neuroblastoma cell line SH-SY5Y, and mouse fibroblast cell line L929. The extracts of sponge and tunicate were found to cause different cytotoxic effects on different cancer cells, largely in a concentration-dependent manner. It is found that the extracts exhibited high anti-cancer activities in neuroblastoma and prostate cancer cell lines at concentrations of 3 and 5 mg/ml. No significant cytotoxic activity was found in L929 cells. In addition, the microscopic examination of cells treated with the extracts shows that the extracts cause morphological changes with cellular rounding, which could be associated with apoptosis.

Keywords


Anti-Cancer Activity, Cytotoxic Activity, Marine Natural Products, Sea Sponge, Tunicate.

References